Optimi Health Corp. (OPTH)
NASDAQ: OPTH · Real-Time Price · USD
4.170
-0.070 (-1.65%)
Jun 23, 2026, 4:00 PM EDT - Market closed
Optimi Health Revenue
Optimi Health had revenue of 99.50K CAD in the quarter ending March 31, 2026, with 62.47% growth. This brings the company's revenue in the last twelve months to 231.86K, down -53.24% year-over-year. In the fiscal year ending September 30, 2025, Optimi Health had annual revenue of 426.30K with 9.35% growth.
Revenue (ttm)
231.86K CAD
Revenue Growth
-53.24%
P/S Ratio
141.10
Revenue / Employee
28,983 CAD
Employees
8
Market Cap
23.44M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 426.30K | 36.45K | 9.35% |
| Sep 30, 2024 | 389.85K | 208.76K | 115.28% |
| Sep 30, 2023 | 181.09K | 100.37K | 124.35% |
| Sep 30, 2022 | 80.72K | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| InterCure | 84.76M |
| Rockwell Medical | 67.68M |
| Aytu BioPharma | 56.60M |
| SCYNEXIS | 20.34M |
| Zhengye Biotechnology Holding | 16.64M |
| China Pharma Holdings | 3.99M |
| TherapeuticsMD | 3.35M |
| China SXT Pharmaceuticals | 1.54M |
OPTH News
- 7 days ago - Optimi launches standardized microdose psilocybin products for clinical research - TheFly
- 7 days ago - Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research - GlobeNewsWire
- 12 days ago - Psychedelic: Optimi Health completes psilocybin export to the UK - TheFly
- 13 days ago - Optimi Health completes first export of naturally derived psilocybin to the UK - TheFly
- 13 days ago - Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial - GlobeNewsWire
- 15 days ago - Optimi Health commences finished ibogaine drug product development - TheFly
- 15 days ago - Optimi Health secures ibogaine supply - TheFly
- 15 days ago - Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development - GlobeNewsWire